- GH -4.13%
Even after rising 7.4% this past week, Guardant Health (NASDAQ:GH) shareholders are still down 74% over the past three years
Yahoo Finance · 6 days ago
Open | 31.44 |
High | 31.44 |
Low | 29.55 |
Mkt Cap | 3.7B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 31.51 |
52 Wk. Low | 15.81 |
52 Wk. High | 41.06 |
Related stocks
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally.
Guardant Health is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 168.49M | 30.90% ▲ |
Net Income | -114.98M | - |
Diluted EPS | -0.94 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.75 | - |
Q1 2024 | -$0.85 | -$0.94 |
Q4 2023 | -$0.86 | -$1.58 |
S&P FuturesES=F | 5,438.50+1.00 (+0.02%) |
Dow FuturesYM=F | 38,604.00-1.00 (-0.00%) |
Nasdaq FuturesNQ=F | 19,712.50+27.00 (+0.14%) |
19,712.50+0.14% | |
5,438.50+0.02% | |
38,604.00-0.00% |